Jalal, Abdullah
Li, Tingting http://orcid.org/0000-0001-7331-9619
Article History
First Online: 14 December 2022
Competing interests
: T.L. receives research support from Travere Therapeutics, Genentech, Omeros Corporation and the US NIH/NIAID, and reports consultancy agreements with ChemoCentryx, Travere Therapeutics, Aurinia Pharmaceuticals, Calliditas Therapeutics and GlaxoSmithKline. A.J. declares no competing interests.